SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-006040
Filing Date
2022-04-27
Accepted
2022-04-27 07:21:46
Documents
16
Period of Report
2022-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20220421x8k.htm   iXBRL 8-K 72116
2 EX-1.1 agrx-20220421xex1d1.htm EX-1.1 282134
3 EX-3.1 agrx-20220421xex3d1.htm EX-3.1 14285
4 EX-5.1 agrx-20220421xex5d1.htm EX-5.1 11312
5 EX-99.1 agrx-20220421xex99d1.htm EX-99.1 12517
  Complete submission text file 0001558370-22-006040.txt   595238

Data Files

Seq Description Document Type Size
6 EX-101.SCH agrx-20220421.xsd EX-101.SCH 3183
7 EX-101.LAB agrx-20220421_lab.xml EX-101.LAB 16587
8 EX-101.PRE agrx-20220421_pre.xml EX-101.PRE 10533
10 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20220421x8k_htm.xml XML 5046
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 22856341
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences